Raymond James & Associates’s MEDIVATION, INC. MDVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-15,599
Closed -$941K 3390
2016
Q2
$941K Buy
15,599
+9,587
+159% +$544K ﹤0.01% 1763
2016
Q1
$276K Sell
6,012
-27,170
-82% -$985K ﹤0.01% 2393
2015
Q4
$1.6M Sell
33,182
-1,716
-5% -$74K 0.01% 1380
2015
Q3
$1.48M Sell
34,898
-14,270
-29% -$707K 0.01% 1376
2015
Q2
$2.81M Buy
49,168
+8,840
+22% +$545K 0.01% 1135
2015
Q1
$2.6M Buy
+40,328
New +$2.31M 0.01% 1091

Other funds holding MDVN

Raymond James & Associates's MDVN Position: Q3 2016 in Review

Raymond James & Associates sold out of MEDIVATION, INC. (MDVN) in Q3 2016, closing a stake of 15,599 shares — an estimated $941K sold.

Raymond James & Associates first reported a position in MDVN in Q1 2015 and held it in 6 quarters. The position peaked at $2.81M in Q2 2015. 53 funds tracked by Wall St. Rank hold MDVN as of Q3 2016.

  • Raymond James & Associates reported no remaining MEDIVATION, INC. position as of Q3 2016 after selling out during the quarter.
  • Raymond James & Associates sold 15,599 MEDIVATION, INC. shares in Q3 2016, an estimated $941K.
  • Raymond James & Associates first reported a position in MEDIVATION, INC. in Q1 2015 and held it in 6 quarters.
  • Raymond James & Associates's MEDIVATION, INC. position peaked at $2.81M in Q2 2015.
  • 53 funds tracked by Wall St. Rank held MEDIVATION, INC. as of Q3 2016.

Based on Raymond James & Associates's 13F filing for Q3 2016, filed 14 Nov 2016.